Reorganizing into a customer-needs-driven R&D organization and accelerating development
First written in FY2016. 21 of 27 entries say "Restated". Latest entry: FY2026.
3 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「The Group's research and development activities have focused on accurately identifying customer needs in each business division, strengthening and expanding its core businesses, exploring peripheral fields of each business, and advancing research and development aimed at establishing new businesses. The Group had 117 research and development staff during the consolidated fiscal year, and total research and development expenses for the consolidated fiscal year were ¥1,653 million.」
The Group continued its research and development policy of focusing on customer needs, strengthening and expanding its core businesses, exploring peripheral fields and commercializing new businesses. Research and development staff totaled 117, and research and development expenses were ¥1,653 million. - FY2026-H1RestatedAnnual report
「The total amount of research and development activities during the interim consolidated accounting period was ¥815 million. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」
The company continued to state that there were no material changes in its research and development activities and disclosed total research and development expenses of ¥815 million for the interim period. - FY2025AdvancedAnnual report
「The Group's research and development activities during the consolidated fiscal year focused on accurately identifying customer needs in each business division, strengthening and expanding its core businesses, exploring peripheral fields of each business, and advancing research and development aimed at establishing new businesses. The Group had 123 research and development staff during the consolidated fiscal year, and total research and development expenses for the consolidated fiscal year were ¥1,753 million.」
The Group continued to focus on customer needs, strengthen its core businesses, explore peripheral fields and commercialize new businesses. Research and development staff totaled 123, and research and development expenses were ¥1,753 million. - FY2025-H1RestatedAnnual report
「The total amount of research and development activities during the interim consolidated accounting period was ¥779 million. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」
The company stated that there were no material changes in its research and development activities and disclosed total research and development expenses of ¥779 million for the interim period. - FY2024AdvancedAnnual report
「The Group's research and development activities have focused on accurately identifying customer needs in each business division, strengthening and expanding its core businesses, exploring peripheral fields of each business, and advancing research and development aimed at establishing new businesses. The Group had 114 research and development staff during the consolidated fiscal year, and total research and development expenses for the consolidated fiscal year were ¥1,424 million.」
The Group continued to focus on customer needs, strengthen its core businesses and explore peripheral fields, and disclosed 114 research and development staff and research and development expenses of ¥1,424 million. - FY2024-Q3RestatedAnnual report
「The total amount of research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥1,066 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company stated that there were no material changes in its research and development activities and disclosed total research and development expenses of ¥1,066 million for the cumulative third quarter. - FY2024-Q2RestatedAnnual report
「The total amount of research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥709 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company stated that there were no material changes in its research and development activities and disclosed total research and development expenses of ¥709 million for the cumulative second quarter. - FY2023-Q3RestatedAnnual report
「Total R&D expenses for the third quarter cumulative period were ¥964 million. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative period.」
The company stated that there were no material changes in the status of R&D activities and disclosed total R&D expenses of ¥964 million for the third quarter cumulative period. - FY2023-Q1RestatedAnnual report
「Total R&D expenses for the first quarter cumulative period were ¥297 million. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative period.」
The company stated that there were no material changes in R&D activities and disclosed total R&D expenses of ¥297 million for the first quarter cumulative period. - FY2022AdvancedAnnual report
「The Group's R&D activities have focused on accurately identifying customer needs in each business division, strengthening and expanding its core businesses, exploring adjacent fields of each business and promoting R&D aimed at establishing new businesses. The Group had 109 R&D staff during the consolidated fiscal year, and total R&D expenses were ¥1,117 million.」
The company continued to focus on customer needs, strengthen its core businesses, explore adjacent fields and establish new businesses, and disclosed 109 R&D staff and ¥1,117 million in R&D expenses. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the second quarter cumulative period were ¥529 million. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative period.」
The company stated that there were no material changes in the status of R&D activities and disclosed total R&D expenses of ¥529 million for the second quarter cumulative period. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the first quarter cumulative period were ¥263 million. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative period.」
The company stated that there were no material changes in R&D activities and disclosed total R&D expenses of ¥263 million for the first quarter cumulative period. - FY2021RestatedAnnual report
「The Group's R&D activities have focused on accurately identifying customer needs in each business division, strengthening and expanding its core businesses, exploring adjacent fields of each business and promoting R&D aimed at establishing new businesses.」
The company continued product development driven by customer needs, strengthened its core businesses and explored adjacent fields and new businesses. It had 98 R&D staff and R&D expenses of ¥1,159 million. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the third quarter cumulative period were ¥871 million. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative period.」
The company stated that there were no material changes in R&D activities and disclosed total R&D expenses of ¥871 million for the third quarter cumulative period. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the second quarter cumulative period were ¥571 million. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative period.」
The company stated that there were no material changes in R&D activities and disclosed total R&D expenses of ¥571 million for the second quarter cumulative period. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the first quarter cumulative period were ¥282 million. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative period.」
The company stated that there were no material changes in R&D activities and disclosed total R&D expenses of ¥282 million for the first quarter cumulative period. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the third quarter cumulative period were ¥840 million. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative period.」
The company stated that there were no material changes in R&D activities and disclosed total R&D expenses of ¥840 million for the third quarter cumulative period. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the first quarter cumulative period were ¥264 million. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative period.」
The company stated that there were no material changes in R&D activities and disclosed total R&D expenses of ¥264 million for the first quarter cumulative period. - FY2019AdvancedAnnual report
「During the consolidated fiscal year, the Group's R&D activities focused on accurately identifying customer needs in each business division, strengthening its core businesses and promoting R&D aimed at establishing new businesses. The Group had 103 R&D staff during the consolidated fiscal year, and total R&D expenses were ¥1,118 million.」
The company continued R&D driven by customer needs, strengthening its core businesses and establishing new businesses, and disclosed 103 R&D staff and ¥1,118 million in R&D expenses. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the third quarter cumulative period were ¥840 million. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative period.」
The company stated that there were no material changes in R&D activities and disclosed total R&D expenses of ¥840 million for the third quarter cumulative period. - FY2019-Q2RestatedAnnual report
「Total R&D expenses for the second quarter cumulative period were ¥572 million. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative period.」
The company stated that there were no material changes in R&D activities and disclosed total R&D expenses of ¥572 million for the second quarter cumulative period. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the first quarter cumulative period were ¥298 million. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative period.」
The company stated that there were no material changes in R&D activities and disclosed total R&D expenses of ¥298 million for the first quarter. - FY2018AdvancedAnnual report
「During the consolidated fiscal year, the Group's R&D activities focused on accurately identifying customer needs in each business division, strengthening its core businesses and promoting R&D aimed at establishing new businesses. The Group had 103 R&D staff during the consolidated fiscal year, and total R&D expenses were ¥1,114 million.」
The company continued R&D driven by customer needs, with 103 R&D staff and ¥1,114 million in R&D expenses. - FY2018-Q3RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
There have been no material changes in R&D activities, and the policy of organizing R&D around customer needs and accelerating development remains in place. - FY2018-Q2RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
There have been no material changes in R&D activities, and the policy of organizing R&D around customer needs and accelerating development remains in place. - FY2018-Q1RestatedAnnual report
「There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The company states that there have been no material changes in its R&D activities and that its policy of organizing R&D around customer needs and accelerating development remains in place. - FY2016First statedAnnual report
「The company will reorganize its R&D structure into organizations directly linked to each business, with the aim of focusing on development based on customer needs and promoting the development of core and production technologies that support growth in its core businesses. It will develop products and accelerate the development process.」
R&D will be reorganized into organizations directly linked to each business to address customer needs and accelerate the development of core technologies, production technologies and products.